Justin Hamilton, CEO of Hempleton Investment Group, speaks with Jason Pickle about the launch of Prolifera

Prolifera is dedicated to redefining the future of the cannabis industry during these uncertain times. Built around a line of cutting edge instant release tablets, Prolifera produces all new cannabis products made using familiar oil based pharmaceutical technology. This delivery method offers consumers a consistent baseline dose of rare, minor cannabinoids in a instant release tablet form. https://shopprolifera.com/

​Hempleton Investment Group Information: “December 2015, we began a mission of developing an Ecosystem of investments that worked together for the common goal of a vertical supply chain, Farm to Farmacy. We obtained that vertical alignment in 2018. In 2019 we positioned ourselves to take our first strategic financial partner, to complete infrastructure expansions, and to complete the rebranding of the Hemp Farmacy for a franchise release.

Now in 2020, we are positioned to once again redefine the cannabis space around individual formulated products, medical hemp product lines, and future pharma expansion projects. Hempleton is positioned for exciting new acquisition opportunities and expansions to widen the vertical alignment, and expand the footprint of the franchise. During a time when so many early companies in this space are failing, Hempleton continues to expand as a debt-free powerhouse with strong revenue and development teams that are successfully navigating the unstable pandemic economy. https://hempleton.com/​

Volunteer Botanicals develops precise cannabinoid formulations, providing manufacturers with consistent, versatile hemp-based ingredients for use in a wide variety of products that meet specific demands of product creators inside and outside the hemp industry. The company’s products provide the building blocks of miscible and “flowable” powders suited for food, beverage, supplements, nutraceutical and pharmaceutical products. Through innovation and technology, Volunteer Botanicals is taking cannabinoids mainstream. For more information, visit https://volunteerbotanicals.com​.